Location: Home
  • search
  • go
  • Relate News
  • 8/10/2015Reuters: China's Hyped Healthcare Reform Is Stuck
  • 8/10/2015NHFPC Report Four Breakthroughs for Public Hospital Reform
  • 8/10/2015Recent Executive and Official Moves
  • 8/10/2015Bringing Innovation to China
  • 8/10/2015Fortune Favors the Prepared: Navigating the Risks and Opportunities of...
  • 8/7/2015Sorrento Licenses Four mAbs from Mabtech
  • 8/7/2015Financial-related Company News in Brief
  • 8/6/2015Novo Nordisk Remain Upbeat with Outlook and Investment Despite Fallen ...
  • 8/6/2015Pharma MNCs Report Slump in Q2/2015 China Performance
  • 8/6/2015China's Western Medicine Trade Growth Slowed Further in the First Half
  • 8/5/2015Domestic Companies Report Growth and Intensified M&A Activitie...
  • 8/4/2015CFDA Likely to Put Online Prescription Drug Sales on Hold
  • 8/4/2015CDE Solicits Comments on Technical Guidelines for Clinical Trials of P...
  • 8/1/2015Chinese Animal Vaccine Industry Report 2015
  • 7/31/2015Pharma Formulation Export Maintains Growth As Import Slows in H1
  • 7/28/2015Why China's Public Healthcare Insurance Advancements Matter
  • 7/28/2015Alibaba Health, CPIC Test Water with Online Health Insurance
  • 7/28/2015Hengrui Medicine Enters Strategic Alliance with Shuwen Biotech for Cam...
  • 7/27/2015Rumors Emerge as BMI Uniform Payment Price Scheme Looms
  • 7/27/2015Latest Amendment of the PRC Drug Administration Law Reissued Officiall...
  • 7/27/2015KPMG: Indian Bulk Drug Industry Faces More Threat from Chinese API Imp...
  • 7/27/2015Yabao Pharma, Lawson Enter R&D Partnership for Sepsis Drug
  • 7/27/2015Eddingpharm to Initiate Phase I Trial of Cardiome's Cardiology Drug
  • 7/26/2015CFDA Seeks Comments on Draft "Testing Guidelines for Imported Dru...
  • 7/26/2015State Council Withdraws 62 Professional Qualifications Including Medic...
  • 7/24/2015China to Provide Universal Major Medical Insurance to Residents This Y...
  • 7/24/2015Bottlenecks for Development of China's Mobile Health Business
  • 7/24/2015Biosimilars Are Regulated Differently in China
  • 7/24/2015Shenzhen Hepalink Acquires A Sizable Stake in Resverlogix
  • 7/24/20153SBio Acquires Zhejiang Wansheng Pharmaceutical for $85M
  • Page:200/334 Total number of articles:10001: [First][<<] [198] [199] [200] [201] [202] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group